MicroPort Orthopedics Expands Commercial Leadership Team with Global Vice President of Marketing and Professional Education and North America Vice President of Sales

Strategic new hires join medical device company to accelerate US and global commercial operations

MicroPort Orthopedics, a global leader in orthopedic devices and technologies, announces today the expansion of its commercial leadership team with two strategic hires: Brian Collins is joining as Global Vice President of Marketing and Professional Education and Shawn Gabriel as Vice President of Sales, North America. Both Brian and Shawn have extensive experience in sales and marketing for medical devices.

Brian Collins brings more than 12 years of experience in the medical device industry-leading strategy and execution to the MicroPort Orthopedics team. In his most recent role as Global Vice President of Marketing and Medical Education for ZimVie, he guided the successful spin-off from Zimmer Biomet. Prior to ZimVie, Brian held various roles in Sales, National Accounts, and Marketing for companies such as Stryker, Depuy Synthes, and Zimmer Biomet. As MicroPort Orthopedics VP of Marketing and Professional Education, Brian is excited to leverage their clinical implant history, paired with upcoming enabling technology launches, to improve surgical guidance for their customers and improve outcomes for their patients.

Shawn Gabriel has over 20 years of experience in the medical device industry leading sales teams and exceeding performance goals. Shawn has worked for Johnson & Johnson, Smith & Nephew, Medtronic, Tornier, and HillRom. During the various roles held at these companies, he has continuously demonstrated excellence in revenue growth, sales team effectiveness, and solution selling of medical devices. He has experience in leading sales teams within an independent distribution network, as well as direct sales. In his previous roles, Shawn has consistently fostered cultures aligned with company values and focused on delivering performance as a cohesive unit. As MicroPort Orthopedics VP of Sales for North America, Shawn will bring his experience and leadership to align and exceed sales goals.

“Brian and Shawn’s expertise will equip our commercial leadership team with the tools necessary to continue our strategic growth in the US and beyond,” said Rob Cripe, Chief Commercial Officer of MicroPort Orthopedics. “These additions to our team are another way that MicroPort is prioritizing advancing itself as a leader in the medical device industry.”

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.